|
LOC100128191 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.2458000000003E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.515200E-03 |
| Normal-vs-Stage2 |
6.074300E-02 |
| Normal-vs-Stage3 |
7.218500E-03 |
| Normal-vs-Stage4 |
2.81619999997762E-06 |
| Stage1-vs-Stage2 |
8.557800E-01 |
| Stage1-vs-Stage3 |
4.167600E-01 |
| Stage1-vs-Stage4 |
6.205200E-04 |
| Stage2-vs-Stage3 |
4.481600E-01 |
| Stage2-vs-Stage4 |
1.724960E-03 |
| Stage3-vs-Stage4 |
9.784200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.80639999999888E-05 |
| Normal-vs-AfricanAmerican |
2.175800E-03 |
| Normal-vs-Asian |
8.222300E-02 |
| Caucasian-vs-AfricanAmerican |
5.403400E-01 |
| Caucasian-vs-Asian |
3.334200E-01 |
| AfricanAmerican-vs-Asian |
4.374600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.95079999999659E-05 |
| Normal-vs-Female |
8.774500E-04 |
| Male-vs-Female |
5.888000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.831840E-02 |
| Normal-vs-Age(41-60Yrs) |
7.98379999999987E-05 |
| Normal-vs-Age(61-80Yrs) |
2.395900E-04 |
| Normal-vs-Age(81-100Yrs) |
3.997200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.471400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.370800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.615800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.275600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.322000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.545800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.608000E-02 |
| Normal-vs-Grade 2 |
2.379200E-03 |
| Normal-vs-Grade 3 |
7.74290000000732E-05 |
| Normal-vs-Grade 4 |
3.598600E-03 |
| Grade 1-vs-Grade 2 |
5.685000E-01 |
| Grade 1-vs-Grade 3 |
8.118600E-01 |
| Grade 1-vs-Grade 4 |
5.284800E-01 |
| Grade 2-vs-Grade 3 |
9.575900E-02 |
| Grade 2-vs-Grade 4 |
1.412210E-01 |
| Grade 3-vs-Grade 4 |
5.981800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.584600E-03 |
| Normal-vs-ccB subtype |
3.142200E-03 |
| ccA subtype-vs-ccB subtype |
2.838400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.54530000000741E-05 |
| Normal-vs-N1 |
2.074000E-02 |
| N0-vs-N1 |
4.913200E-01 |
|
|
